Previously, genetic reduction of endogenous tau was reported to reduce interictal spiking and spontaneous seizures besides ameliorating cognitive deficit without affecting Aβ pathology in the J20 (hAPP) mouse model of AD (Roberson et al., 2007). Here, MAPT is linked to Alzheimer disease.